Complementary and alternative medicine costs - A systematic literature review

Forschende Komplementarmedizin

Volumn 13, Issue 2, 2006, Pages 42-45

  Maxion Bergemann, Stefanie ^a   Wolf, Martin ^b   Bornhöft, Gudrun ^a,c   Matthiessen, Peter F ^a,c   Wolf, Ursula ^d  

^a PanMedion Foundation   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Alternative therapies; Complementary medicine; Cost effectiveness; Health economics

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; GINKGO BILOBA EXTRACT;

ABSENTEEISM; ALTERNATIVE MEDICINE; BUDGET; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; DATA ANALYSIS; DATA BASE; DEMENTIA; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HOMEOPATHY; HUMAN; LEG COMPRESSION; MEDICAL LITERATURE; MEDICAL PRACTICE; METHODOLOGY; PHYTOTHERAPY; PROSPECTIVE STUDY; PUBLICATION; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SWITZERLAND; SYSTEMATIC REVIEW; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; ANXIETY DISORDER; COST EFFECTIVENESS ANALYSIS; GINKGO BILOBA; RHEUMATOID ARTHRITIS; RHINITIS;

COMPLEMENTARY THERAPIES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; SWITZERLAND; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 33745764347     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000093313     Document Type: Review

References (39)

1. Bundesamt für Statistik. StatSanté: Gesundheitskosten in der Schweiz. 2003:12. www.statistik. admin.ch/stat_ch/ber14/statsant/statsante_1- 2003_d.pdf.
2. Beer A-M, Ostermann T, Matthiessen PF: Evaluation stationärer Naturheilkunde - Das Blankensteiner Modell. Teil 1: Patientenklientel und therapeutische Konzepte. Forsch Komplementärmed Klass Naturheilkd 2001;8:6-13.
3. Buchbinder R, Gingold M, Hall S, Cohen M: Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practice. Intern Med 2002;32:208-214.
4. Egede LE, Ye X, Zheng D, Silverstein MD: The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 2002;25(2):324-329.
5. Ernst E, White A: The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000;8:32-36.
6. Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS: Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998;158:2257-2264.
7. Friedman R, Sedler M, Myers P, Benson H: Behavioral medicine, complementary medicine and integrated care. Economic implications. Prim Care 1997;24:949-962.
8. Furler M, Walmsley TR: Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Pat Care Stand 2003;17:155-68.
9. Güthlin C, Lange O, Walach H: Measuring the effects of acupuncture and homoeopathy in general practice: An uncontrolled prospective documentation approach. BMC Pub Health 2004;4:6.
10. Mac Lennan AH, Wilson DH, Taylor AW: Prevalence and costs of alternative medicine in Australia. Lancet 1996;347:569-73.
11. Marx HH: The dilemma of effectiveness and economic value of alternative medicine. Gesundheitswesen 1997;59:297-301.
12. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, et al: Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 2002;8:477-85.
13. Ramsey SD, Spencer AC, Topolski TD, Belza B, Patrick DL: Use of alternative therapies by older adults with osteoarthritis. Arthritis Care Res 2001;45:222-7.
14. Rees RW, Feigel I, Vickers A, Zollman C, McGurk R, Smith C: Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer 2000;36:1359-64.
15. Schafer T, Riehle A, Wichmann HE, Ring J: Alternative medicine in allergies - prevalence, patterns of use, and costs. Allergy 2002;57:694-700.
16. Shenfield G, Lim E, Allen H, et al: Survey of the use of complementary medicines and therapies in children with asthma. J Paediatr Child Health 2002;38:252-7.
17. Sommer J, Burgi M, Theiss R: A randomized experiment of the effects of including alternative medicine in the mandatory benefit package of health insurance funds in Switzerland. Complement Ther Med 1999;7:54-61.
18. Sommer J, Burgi M, Theiss R: Inclusion of complementary medicine increases health costs. Focus Altern Complement Ther 1999;4:183-4.
19. Sommer J: Gesundheitsökonomische Analyse der Wirkungen des Angebots komplementärmedizinischer Leistungen der Krankenkassen. Forsch Komplementärmed 1999;6:7-9.
20. Stewart D, Weeks J, Bent S: Utilization, patient satisfaction, and cost implications of acupuncture, massage, and naturopathic medicine offered as covered health benefits: a comparison of two delivery models. Altern Ther Health Med 2001;7:66-70.
21. Thomas KJ, Nicholl JP, Coleman P: Use and expenditure on complementary medicine in England: A population based survey. Complement Ther Med 2001;9:2-11.
22. Van Haselen RA, Graves N, Dahiha S: The costs of treating rheumatoid arthritis patients with complementary medicine: Exploring the issue. Complement Ther Med 1999;7:217-21.
23. Von Gruenigen VE, White LJ, Kirven MS, Showalter AL, Hopkins MP, Jenison EL: A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 2001;11:205-9.
24. Walach H, Heinrich SS, Esser P: The test phase of the Innungskrankenkassen on acupuncture and homeopathy. Forsch Komplementärmed Klass Naturheilkd 1997;4:121.
25. Bleul G: Kostenvergleich Homöopathie/konventionelle Medizin am Beispiel zweier Fälle von akutem Tinnitus. Allg Hom Z 1997;242:190-198.
26. Chaufferin G: Improving the evaluation of homeopathy: economic considerations and impact on health. Br Hom J 2000;89:27-30.
27. Heger M, Riley DS, Haidvogl M, Gordon D, Herrick N, Wolscher U: IIPCOS - Ein internationales Projekt zur Untersuchung der Effektivität der Homöopathie in der ärztlichen Primärversorgung. Hom Int R D Newslett 2001;2:3-19.
28. Schlüren E: Vergleich der Arzneimittelkosten bei homöopathischer und allopathisch-schulmedizinischer Behandlung. Vergleich der Arznermittelkosten. Allg Hom Z 1984;229:160-161.
29. Schüppel R: Kosten und Nutzen der Homöopathie - Ein echtes Schnäppchen? Hausarzt 2003;19:64.
30. Swayne J: The cost and effectiveness of homeopathy. Br Hom J 1992;1:148-50.
31. Taieb C, Myon E: The economic impact of homeopathic management: the French example (ISPOR Poster). Value Health 2003;1:373.
32. Trichard M, Chaufferin G, Nicoloyannis N: Pharmacoeconomic comparison between two drug strategies of treatment of anxiety disorders: homeopathy and psychotropics (ISPOR Poster PMH23). Value in Health 2003;6:350-1.
33. van Haselen R, Fisher P: The economic evaluation of complementary medicine: a staged approach at the Royal London Homeopathic Hospital. Br Hom J 2000;89:23-6.
34. van Wassenhoven M, Unio hoemopathica Belgica: An oberservational study of patients receiving homeopathic treatment, Survey 2001, Study Report 2003.
35. Wemmer U: Gesundheitspolitik - Kostendämpfung durch Antihomotoxika bei der Behandlung grippaler Infekte. Biol Med 1997;25:218-22.
36. Wiesenauer M, Groh P, Häussler S: Naturheilkunde als Beitrag zur Kostendämpfung. Fortschr Med 1992;110:31-38.
37. Rychlik R, Marschall M, Bachinger A: Ökonomische Aspekte der Therapie der chronisch venösen Insuffizienz. Qual Manag 1997;2:86-91.
38. Hörr R, Kieser M: Pharmakoökonomische Bewertung von Ginkgo-Spezialextrakt (Egb761®) im Indikationsgebiet dementielle Erkankungen bezogen auf Österreich. Wien Med Wochenschr 2002;152:427-31.
39. Heusser P: Komplementärmedizin in der Grundversicherung: Verteuert sie die Gesundheitskosten? Schweiz Z Ganzheitsmedizin 1999;11:4-9.